CANADIAN SOLAR INC.
FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
REPORT OF FOREIGN ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF THE
SECURITIES EXCHANGE ACT OF 1934
For the month of July 2008
Commission File Number: 001-33107
CANADIAN SOLAR INC.
No. 199 Lushan Road
Suzhou New District
Suzhou, Jiangsu 215129
Peoples Republic of China
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form
20-F or Form 40-F.
Form 20-F þ Form 40-F o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(1): o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(7): o
Indicate by check mark whether by furnishing the information contained in this Form, the registrant
is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.
Yes o No þ
If Yes is marked, indicate below the file number assigned to the registrant in connection with
Rule 12g3-2(b):
82- N/A
CANADIAN SOLAR INC.
Form 6-K
TABLE OF CONTENTS
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
CANADIAN SOLAR INC.
|
|
|
By: |
|
/s/ Shawn (Xiaohua) Qu
|
|
|
Name: |
Shawn (Xiaohua) Qu
|
|
|
Title: |
Chairman, President and
Chief Executive Officer |
|
|
Date: July 17, 2008
EX-99.1 PRESS RELEASE
Exhibit 99.1
Canadian Solar Announces Pricing of
its Follow-On Public Offering of Common Shares
Jiangsu, China, July 17, 2008 Canadian Solar Inc. (NASDAQ: CSIQ) (Canadian Solar or the
Company) today announced further details regarding its follow-on public offering of common shares
(the Offering).
Details of the Offering
A total of 3,500,000 common shares are being sold in the Offering at a price of $34.00 per
share. In addition, the underwriters have been granted a 30-day option to purchase up to 525,000
common shares from the Company solely to cover over-allotments. The Companys common shares are
traded on the Nasdaq Global Market under the ticker symbol CSIQ.
Deutsche Bank Securities Inc. and Piper Jaffray & Co. are acting as joint bookrunners for the
Offering. The underwriters expect to deliver the common shares to purchasers on or about July 22,
2008, subject to the satisfaction of customary closing conditions.
This press release does not constitute an offer to sell or a solicitation of an offer to buy the
securities described herein, nor shall there be any sale of these securities in any state or
jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration
or qualification under the securities laws of any such state or jurisdiction.
The Offering is made only by means of a prospectus supplement forming a part of the
registration statement. A copy of the prospectus supplement relating to the offering may be
obtained by contacting Deutsche Bank Securities Inc., Attn: Prospectus Department, 100 Plaza One,
Floor 2, Jersey City, NJ 07311-3901, by telephone at 1-800-503-4611, or by e-mail at
prospectusrequest@list.db.com; or by contacting Piper Jaffray & Co., Attn: Beth Davidge, 800 Nicollet Mall, Suite 800,
Minneapolis MN 55402, by telephone at 1-877-371-5212, or by e-mail at
Beth.k.davidge@pjc.com.
On closing of the Offering, before any exercise of the over-allotment option, there will be
35,629,138 shares in issue.
Certain statements in this press release may be forward-looking statements, as defined in the
Private Securities Litigation Reform Act of 1995. Generally, the words believe, expect,
intend, anticipate, will, may and similar expressions identify forward-looking statements.
These statements are only predictions. The Company makes these forward-looking statements based on
information available on the date hereof, and it has no obligation (and expressly disclaims any
such obligation) to update or alter any such forward-looking statements, whether as a result of new
information, future events, or otherwise. See the Companys Form 20-F for the period ended
December 31, 2007 for a further discussion of these and other risks and uncertainties applicable to
the Companys business.